Lung cancer drug ruled too expensive for English patients - The Telegraph 25th April 2008

Thousands of lung cancer patients in England will be denied a drug which could prolong their life after it was ruled too expensive by the NHS watchdog. Guidance issued to NHS doctors by the National Institute for Clinical Excellence (Nice) claims that the drug Tarceva is not a good use of "scarce resources". However, it will remain available in Scotland.

Link to Article